Simultaneous liquid chromatographic assay of amantadine and its four related compounds in phosphate-buffered saline using 4-fluoro-7-nitro-2,1,3-benzoxadiazole as a fluorescent derivatization reagent

Biomedical Chromatography

Volumn 20, Issue 5, 2006, Pages 423-428

  Higashi, Yasuhiko ^a   Nakamura, Shota ^a   Matsumura, Hiroki ^a   Fujii, Youichi ^a  

^a HOKURIKU UNIVERSITY   (Japan)

Author keywords

4 fluoro 7 nitro 2,1,3 benzoxadiazole; Amantadine; Amantadine related compound; Pre column derivatization; 1 acid glycoprotein

Indexed keywords

AMINES; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

4-FLUORO-7-NITRO-2,1,3-BENZOXADIAZOLE; AMANTADINE; AMANTADINE-RELATED COMPOUND; MEMANTINE; PHOSPHATE-BUFFERED SALINES; PRE-COLUMN DERIVATISATION; RELATED COMPOUNDS; RIMANTADINE; Α1-ACID GLYCOPROTEIN;

GLYCOPROTEINS;

1 ADAMANTANMETHYLAMINE; 2 ADAMANTANAMINE; ACETONITRILE; AMANTADINE; AMANTADINE DERIVATIVE; BORIC ACID; MEMANTINE; OROSOMUCOID; PHOSPHATE BUFFERED SALINE; PYRROLE DERIVATIVE; REAGENT; RIMANTADINE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BINDING AFFINITY; CALCULATION; CONTROLLED STUDY; DERIVATIZATION; DRUG DETERMINATION; DRUG PROTEIN BINDING; DRUG STRUCTURE; FLUORESCENCE ANALYSIS; LIQUID CHROMATOGRAPHY; PH; SEPARATION TECHNIQUE;

EID: 33646762446     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.577     Document Type: Article

References (31)

1. Aoyama C, Santa T, Tsunoda M, Fukushima T, Kitada C and Imai K. A fully automated amino acid analyzer using NBD-F as a fluorescent derivatization reagent. Biomedical Chromatography 2004; 18: 630-636.
2. Belanger PM and Grech-Belanger O. Gas-liquid chromatographic determination of plasma and urinary levels of amantadine in man. Journal of Chromatography 1982; 228: 327-332.
3. Biandrate P, Tognoni G, Belvedere G, Frigerio A, Rizzo M and Morselli PL. A gas chromatographic method for the determination of amantadine in human plasma. Journal of Chromatography 1972; 74: 31-34.
4. Bleidner WE, Harmon JB, Hewes WE, Lynes TE and Hermann EC. Absorption, distribution and excretion of amantadine hydrochloride. Journal of Pharmacology and Experimental Therapeutics 1965; 15: 484-490.
5. Bryson YJ. The use of amantadine in children for prophylaxis and treatment of influenza A infections. Pediatric Infectious Disease 1982; 1: 44-46.
6. Colgan R, Michocki R, Greisman L and Moore TA. Antiviral drugs in the immunocompetent host: part II. Treatment of influenza and respiratory syncytial virus infections. American Family Physician 2003; 67: 763-766.
7. Dolin R, Reichman RC, Madore HP, Maynard R, Linton PN and Webber-Jones J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. New England Journal of Medicine 1982; 307: 580-584.
8. Englund JA, Champlin RE, Wyde PR, Kantarjian H, Atmar RL, Tarrand J, Yousuf H, Regnery H, Klimov AI, Cox NJ and Whimbey E. Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Clinical Infectious Diseases 1998; 26: 1418-1424.
9. Evidente VG, Adler CH, Caviness JN and Gwinn-Hardy K. A pilot study on the motor effects of rimantadine in Parkinson's disease. Clinical Neuropharmacology 1999; 22: 30-32.
10. Fukushima T, Kawai J, Imai K and Toyo'oka T. Simultaneous determination of D- and L-serine in rat brain microdialysis sample using a column-switching HPLC with fluorimetric detection. Biomedical Chromatography 2004; 18: 813-819.
11. Garrino MG and Henquin JC. Adamantane derivatives: a new class of insulin secretagogues. British Journal of Pharmacology 1987; 90: 583-591.
12. Goralski KB, Smyth DD and Sitar DS. In vivo analysis of amantadine renal clearance in the uninephrectomized rat: functional significance of in vitro bicarbonate-dependent amantadine renal tubule transport. Journal of Pharmacology and Experimental Therapeutics 1999; 290: 496-504.
13. Higashi Y and Fujii Y. Liquid chromatographic determination of 1-adamantanamine and 2-adamantanamine in human plasma after pre-column derivatization with o-phthalaldehyde and 1-thio-beta-D-glucose. Journal of Chromatography B 2004; 799: 349-353.
14. Higashi Y and Fujii Y. Simultaneous determination of the binding of amantadine and its analogues to synthetic melanin by liquid chromatography after pre-column derivatization with dansyl chloride. Journal of Chromatographic Science 2005; 43: 213-217.
15. Higashi Y, Uemori I and Fujii Y. Simultaneous determination of amantadine and rimantadine by HPLC in rat plasma with pre-column derivatization and fluorescence detection for pharmacokinetic studies. Biomedical Chromatography 2005a (in press).
16. Higashi Y, Matsumura H and Fujii Y. Determination of fluvoxamine in rat plasma by high-performance liquid chromatography with pre-column derivatization and fluorescent detection using 4-fluoro-7-nitro-2,1,3-benzoxadiazole. Biomedical Chromatography 2005b (in press).
17. Hoffman HE, Gaylord JC, Blasecki JW, Shalaby LM and Whitney CC Jr. Pharmacokinetics and metabolism of rimantadine hydrochloride in mice and dogs. Antimicrobial Agents and Chemotherapy 1988; 32: 1699-1704.
18. Honda S, Okeda J, Iwanaga H, Kawakami S, Taga A, Suzuki S and Imai K. Ultramicroanalysis of reducing carbohydrates by capillary electrophoresis with laser-induced fluorescence detection as 7-nitro-2,1,3-benzoxadiazole-tagged N-methylglycamine derivatives. Analytical Biochemistry 2000; 286: 99-111.
19. Imai K. Analytical chemical studies on high-performance recognition and detection of bio-molecules in life. Yakugaku Zasshi 2003; 123: 901-917.
20. Koeberle MJ, Hughes PM, Wilson CG and Skellern GG. Development of a liquid chromatography-mass spectrometric method for measuring the binding of memantine to different melanins. Journal of Chromatography B 2003; 787: 313-322.
21. Merello M, Nouzeilles MI, Cammarota A and Leiguarda R. Effect of memantine (NMDA antagonist) on Parkinson's disease: a double-blind crossover randomized study. Clinical Neuropharmacology 1999; 22: 273-276.
22. Miguel-Hidalgo JJ, Alvarez XA, Cacabelos R and Quack G. Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40). Brain Research 2002; 958: 210-221.
23. Paci C, Thomas A and Onofrj M. Amantadine for dyskinesia in patients affected by severe Parkinson's disease. Neurological Sciences 2001; 22: 75-76.
24. Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S and Mobius HJ. Memantine in moderate-to-severe Alzheimer's disease. New England Journal of Medicine 2003; 348: 1333-1341.
25. Scatchard G. The attraction of proteins for small molecules and ions. Annals of the New York Academy of Sciences 1949; 51: 660-672.
26. Sioufi A and Pommier F. Gas chromatographic determination of amantadine hydrochloride (Symmetrel) in human plasma and urine. Journal of Chromatography 1980; 183: 33-39.
27. Spector R. Transport of amantadine and rimantadine through the blood-brain barrier. Journal of Pharmacology and Experimental Therapeutics 1988; 244: 516-519.
28. Stumph MJ, Noall MW and Knight V. Gas-chromatographic determination of amantadine in human urine. Clinical Chemistry 1980; 26: 295-296.
29. Watanabe Y and Imai K. High-performance liquid chromatography and sensitive detection of amino acids derivatized with 7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole. Analytical Biochemistry 1981; 116: 471-472.
30. Watanabe Y and Imai K. Liquid chromatographic determination of amino and imino acids and thiols by postcolumn derivatization with 4-fluoro-7-nitrobenzo-2,1,3-oxadiazole. Analytical Chemistry 1983; 55: 1786-1791.
31. Wingfield WL, Pollack D and Grunert RR. Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occurring influenza A2 respiratory illness in man. New England Journal of Medicine 1969; 281: 579-584.